Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleBevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsAnand B Karnad